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ABSTRACT 
To compare the quality of fundus evaluations conducted with 
natural and dilated pupils, 500 typical adult subjects, divided into 5 
age categories, were examined using both techniques. Direct and 
monocular indirect ophthalmoscopes were used with the natural 
pupils; direct and binocular indirect scopes were used for the 
dilated exams. Retinal anomalies were classified on the basis of 
posterior pole or peripheral location and whether the anomalies 
would require significant action by the doctor. Of the 29 posterior 
pole anomalies which required action, 38% were missed during the 
natural pupil examination; 49% of the anomalies not requiring 
immediate action were also missed. These miss rates, along with 
the 287 anomalies found in the periphery (20 of which required 
immediate action), suggest that dilation should be strongly 
considered for all patients so as to optimize the probability of 
detecting fundus anomalies. 
INTRODUCTION 
Optometrists in all fifty states are now able to use diagnostic 
pharmaceutical agents (DPAs) for performing dilated fundus 
examinations. However, even though mydriatics have been shown to 
be quite safe when used appropriately, 1 questions still remain about 
when to use these drugs. 2 Results of a recent survey3 indicate that 
only 7% of the private practice optometrists who responded include 
a dilated fundus evaluation as a routine part of their examinations. 
Another survey4 found that most members (94%) of an optometric 
panel did not dilate their patients' eyes on a routine and frequent 
basis, 20% did not dilate at all, and one optometrist even commented 
that if the fundus could be seen through the natural pupil, the 
inconvenience of dilation wasn't required for most patients. 
Several authors have examined the question of who and when 
to dilate. Patorgis and Augeri5 approached this question by 
developing tables based on patient age and symptom occurrence to 
indicate when dilation was recommended, and Alexander and 
Scho II es6 established a list of criteria which they considered to be 
"definite indications" for dilation. Although such lists and tables 
are useful, they might also be taken to imply that dilation is not 
indicated for patients presenting without any of the criteria 
specified; this can create a potentially dangerous situation. 
For many optometrists, the current standard of care used by 
the majority of their colleagues dictates who and when to dilate, 
but what is the current standard of care? Alexander and Scholles6 
have pointed out that with respect to dilation " ... the profession is 
moving toward an acceptance of ophthalmic drug use that will 
establish a standard of care requiring even more widespread use of 
this procedure." In a discussion of the optometrist's duty to dilate 
in order to detect retinal detachment, Classe•7 noted that: "Indeed, 
such an examination (i.e., into the periphery) may be a duty ... because 
of the standard of care expected of optometric practitioners 
certified to employ diagnostic agents." 
In a letter to the Journal of the American Optometric 
Association, Lynch8 raised questions regarding liabilities produced 
by dilation. He asked whether the liability associated with an 
automobile accident that results from driving after dilation is of 
greater consequence than the possibility of missing a disease in an 
asymptomatic patient. Classe·9 responded that optometrists need to 
warn their patients regarding possible dangers associated with 
dilation, but he also concluded that " ... the great majority of 
practitioners would maintain that routine dilation - in the absence 
of signs or symptoms of disease - is not the standard of care." This 
implies that the current standard of care mandates the dilation of 
symptomatic patients and those determined to be at high risk of 
disease, but dilation of low risk, asymptomatic patients is not 
required. Responding to this, Silverman 1 0 cited two cases in which 
diseases were discovered in asymptomatic patients as a result of 
routine dilation. He argued that the standard of care as presented by 
Classe' " ... is not good enough for the optometrist of the 1980s and 
certainly represents less than adequate eye care standards in the 
profession at this time." 
What then does the optometrist do with the patient currently 
in the chair? How is the decision made regarding whether or not to 
dilate? Certainly, if there are obvious signs or symptoms of disease 
dilation is required, but what about the asymptomatic patient, or the 
one who was dilated last year (or five years ago), or the patient who 
is only 25 years old? 
As reviewed by Gottschalk, 11 arguments opposing routine 
dilation include the time required for the procedure, the possible 
disruption of the doctor's and patient's schedules, the risk of ocular 
trauma resulting from DPA use, the possibility that the patient will 
have an accident while vision is compromised because of dilation, 
patient dislike of dilation, the knowledge that disease occurrence 
rates are relatively low in most age categories (especially in the 
young), and the presumption that using the direct ophthalmoscope to 
examine the posterior pole through the natural pupil gives an 
adequate view of the most important structures in the eye - the disc 
and macula. 
Arguments in favor of routine and regular dilation include the 
possibilities that disease might occur in the peripheral areas of the 
retina not observable through the natural pupil, that a disease could 
develop within the time since the last examination, and that even in 
young patients with clear media the view of the posterior pole using 
the direct ophthalmoscope through the natural pupil is not as good as 
most optometrists believe it to be. 
To add data to what has largely been an exchange of anecdotes, 
case studies, and opinions, the study reported here was conducted to 
assess the quality of fundus examinations performed with natural 
and dilated pupils. To accomplish this, 500 adult subjects of 
various ages were recruited and examined using direct and 
monocular indirect (MIO) ophthalmoscopes through natural pupils, 
and again using direct and binocular indirect (810) scopes through 
dilated pupils. 
Examination quality was assessed in two ways. First, a 
determination was made regarding how well the posterior pole could 
be examined by counting the number of anomalies found or missed 
with each technique. If a significant number of anomalies were 
found with dilation and missed with the natural pupil, concerns 
would be raised about the quality of the natural pupil examination. 
Benign anomalies, such as nevi, were counted along with serious 
anomalies, like tumors, because the ability to detect the relatively 
common benign anomalies provides a good indication of how well 
less frequently occurring lesions would be found. 
As a second indication of examination quality, counts were 
made of how many benign and serious anomalies were detected in 
the peripheral retina which is not visible through the natural pupil. 
These counts provide an indication of the occurrence rates for 
conditions that would be missed without dilation. 
SUBJECTS AND METHODS 
SUBJECTS 
The subject population consisted of the first 100 volunteers in 
five age categories: 20-29, 30-39, 40-49, 50-59 and 60 plus. 
Subjects were recruited via news stories and were offered a vision 
examination in compensation for project participation. Typical 
subjects were middle class, employed, and in good health. Eighty-
one percent were white, 15% hispanic, 4% asian, and less than 1% 
black; 59% were female and 41% male. 
Of the potential subjects applying for the project, nine (2%) 
were rejected; seven had angles of less than grade 2 (von Herrick) 
and two were on miotic therapy for glaucoma. 
PROCEDURES 
Each subject was assigned a one-hour appointment during 
which the project was explained and an informed consent form 
signed. The subject's fundi were then examined through natural 
(non-dilated) pupils using a Welch Allyn halogen direct 
ophthalmoscope and an American Optical MIO. Standard examination 
techniques were used in which the subject moved his/her eyes to 
various positions of gaze so as to insure that the entire posterior 
pole (the region out to but not including vortex vein insertions), or 
that portion of the posterior pole observable given limitations 
imposed by the subject's pupil size, was examined. White 
ophthalmoscope light was used for all examinations; intensity was 
adjusted to obtain the best view for each subject. Fundus viewing 
times were approximately 1.0 minute per eye with each instrument. 
Following completion of the natural pupil examination, the 
examiner obtained information on the subject's history, and recorded 
normative values for distance Snellen acuity, lens prescription, 
Goldmann lOP, von Herrick angle estimation, ambient-light pupil 
size, and media clarity (five point scale with zero meaning clear and 
4 meaning opaque). These data are summarized in Table 1. Values 
are means for both eyes of all subjects with standard deviations 
Insert Table 1 about here 
shown in parenthesis. Acuities were obtained as Snellen values and 
converted to decimal for calculation and presentation purposes (e.g., 
20/20 equals 1 .0, 20/40 equals 0.5, etc.); lens prescriptions are 
spherical equivalents. Trends associated with increasing age 
include an increase in lOP, and reductions in acuity, myopia, anterior 
angle, pupil size, and media clarity. 
After the natural pupil examination and normative data 
acquisition, the examiner dilated the subject's pupils using a topical 
anesthetic and one drop of 2.5% phenylephrine, followed in 5 minutes 
by one drop of 1% tropicamide. Twenty-three (4.6%) of the subjects 
required a second set of mydriatic drops to achieve adequate 
dilation, and 58 (11 .6%) of the subjects received only tropicamide 
because of cardiovascular problems, diabetes, hyperthyroid, and/or 
medications incompatible with phenylephrine. 
Thirty minutes after final drop instillation, a second examiner, 
without knowledge of the subject's history, normative values, or 
results of the natural pupil examination, examined the subject's 
fundi through the dilated pupils using a Welch Allyn direct 
ophthalmoscope and an Exeter standard 810 with a 200 double 
aspheric, yellow Volk condensing lens. At the time of this second 
examination, mean ambient-light pupil diameters for the 5 age 
categories were 7.5 mm (SO = 0.5), 7.4 mm (0.7), 7.2 mm (0.7), 6.7 
mm (0.7), and 6.6 mm (2.3), in order of increasing age. 
Posterior pole (out to the vortex veins) and peripheral aspects 
(including the vortex veins and beyond) of each fundus were 
examined and anomalies were recorded. Again, standard techniques 
using white lights were used with examination facilitated by having 
the subject move her/his eyes to various positions. Scleral 
indentation was not used. The viewing times for the posterior pole 
of each fundus were approximately 1.0 min for the direct scope and 
0.5 min for the 810; viewing the periphery with the 810 required 
approximately 3.5 min per eye. 
After the dilated fundus examination, Goldmann pressures 
were again measured. Mean and standard deviations of the lOPs for 
the 5 age categories, in order of increasing age, were: 14.7 mm Hg 
(80=2.6), 14.7 mm Hg (2.8), 15.6 mm Hg (2.7), 16.0 mm Hg (3.4), and 
16.9 mm Hg (3.5). Reference to the pre-dilation lOPs shown in Table 
1 indicates that dilation caused a mean decrease of about 0.7 mm Hg 
across all age groups with the decrease being slightly greater for 
the younger subjects. 
After final lOP measurements were made, subjects were 
released with instructions to notify the experimenters if adverse 
reactions to the dilation procedure were noted; no subject found it 
necessary to do so. Except for two subjects who experienced 
transient and self-correcting lOP increases of 9 and 11 mm Hg 
following dilation, no untoward events occurred as a result of 
dilating the 500 subjects in the population. 
EXAMINERS 
Two examiners participated in this project. Both were 
military optometrists with eleven and seven years of practice 
experience, respectively. They were highly skilled with the 
equipment used in the study having each examined over 20,000 
patients. For each subject, one examiner performed the natural pupil 
exam and the other performed the dilated examination. They 
recorded their findings independently and did not disclose them to 
each other until completion of the subject's evaluation. To 
compensate for any differences in anomaly detection ability 
between examiners, they alternated performing non-dilated and 
dilated examinations on consecutive subjects. 
RESULTS 
Table 2 presents the categories of anomalies detected in the 
population. The anomalies are divided into two types: A and 0. Type 
Insert Table 2 about here 
I 
A (Action) anomalies are those which at the time of detection would 
generally require treatment, referral for treatment or immediate 
follow-up care, action to rule out a vision or health threatening 
condition, re-evaluation more frequently than every 4 months, or 
which could pose a current and/or significant threat to vision or 
health. Type 0 (Other) anomalies are those which at the time of 
detection would generally require a notation in the record, 
documentation by photos, etc., re-evaluation less frequently than 
every 4 months, or are those which would not pose a current and/or 
significant threat to vision or health. 
Categorization of anomalies into types A and 0 was 
accomplished by vote of 10 experienced optometrists. There was 
good agreement between the optometrists on classifications but all 
indicated that extenuating circumstances could shift the category of 
an anomaly. (For readers who wish to use their own classification 
system, an Appendix is provided which shows the detection 
frequency for each separate anomaly.) 
Counts of individual subjects with type A or 0 anomalies and 
with anomalies of both types are shown in Table 3. To be included 
Insert Table 3 about here 
in these counts, a subject had to have one or more anomalies in 
either or both eyes, but no matter how many separate anomalies 
were observed in a single subject, she or he was counted only once. 
Of the 500 subjects, well over half of them (63%) had an ocular 
anomaly and about 8% of them had a type A anomaly which would 
require action by the doctor. 
Table 4 shows summary counts of type A (A), type 0 (0), and 
total (T) anomalies detected during the natural pupil and dilated 
Insert Table 4 about here 
examinations. (See Appendix for counts of specific anomalies.) For 
this Table, the posterior pole was defined as that part of the retina, 
maximally limited by the vortex vein insertions, which could be seen 
using the natural or the dilated pupils. This meant that if a subject 
had small pupils, the area obseNed and defined as the posterior pole 
would be smaller for the natural pupil examination than the area 
observed and defined as the posterior pole for the dilated 
examination. 
In Table 4, anomalies detected, not subjects, are counted so 
that each subject could contribute several counts if she or he had 
multiple anomalies. (Multiple occurrences of the same anomaly, e.g., 
several nevi in one or both eyes of the same subject were counted as 
only one occurrence.) Values shown as "percent missed" were 
determined by expressing the difference between the natural pupil 
and dilated counts as a percentage of the dilated count. A pattern is 
consistent across age and anomaly categories: detection rates are 
higher for posterior pole anomalies when dilation techniques were 
used. 
Using conventional examination techniques, anomalies 
occurring in the retinal periphery (i.e., beyond the vortex vein 
insertions) are difficult or impossible to detect through the natural 
pupil. Table 5 shows the 287 anomalies which would have been 
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missed if the population of 500 subjects had not been dilated. (See 
Appendix for counts of specific anomalies.) 
DISCUSSION 
The number of posterior pole and peripheral anomalies missed 
in this study indicates a difference in quality between the two 
fundus examination techniques. But how important is this 
difference, why are there so many posterior pole anomalies missed 
without dilation, and is the difference in quality sufficient to 
suggest that the current standard of optometric care be changed to 
replace natural pupil fundus exams with dilated examinations? 
The importance of the difference in quality can be assessed by 
considering the miss rates for various anomalies and the problems 
that could occur for both patient and doctor if these anomalies were 
not detected. Failure to dilate any of the subjects in this study 
(which is apparently the standard of practice used by 20% of the 
optometrists in the Review of Optometry panel4 ) would mean that 
12 type A posterior pole anomalies and 20 type A peripheral 
anomalies would have gone undetected. In each of these cases, a 
vision or life threatening condition could have been missed and a 
significant personal and/or legal tragedy might have resulted. The 
difference in examination quality is, therefore, very important. 
While it is expected that peripheral anomalies would not be 
found without dilation, it is surprising that almost half of the 
posterior pole anomalies were missed. Why was the miss rate so 
high? There are at least three possibilities. First, it might be 
assumed that most of the missed anomalies were in older subjects 
with small pupils and cloudy media; small pupils would limit the 
area of the retina observable and cloudy media could make detection 
of anomalies difficult. The importance of these factors can be 
evaluated by referring to Tables 1 and 4. Table 1 shows a steady 
decrease in pupil size with increasing age and a decrease in media 
clarity for patients over the age of 50. If media clarity and pupil 
size were the major contributors to the high posterior pole miss 
rate, the miss rates for all anomalies should increase with age. 
This is not the case (see Table 4). For nevi, the miss rate shows no 
such trend, nor are there trends for most of the other anomalies. 
The total miss rates for subjects age 30 and over also do not 
demonstrate a clear association with age. Overall, pupil size and 
media clarity did not seem to play a major role in determining why 
so many more posterior pole anomalies are found with dilation. 
Another factor which might explain the higher anomaly 
detection rate for dilated examinations is the stereopsis provided by 
the 810. In several cases, especially those involving elevated or 
depressed anomalies of the disc or macula, the lesion could be seen 
easily with the 810 but could not be detected using the direct or MIO, 
even when its location was known to the examiner. (The importance 
of stereo cues for anomaly detection raises interesting questions 
about the quality of an examination conducted by an optometrist who 
cannot achieve stereopsis with the 810, but such questions are 
beyond the scope of this paper.) 
A third factor which might explain the difficulty in detecting 
posterior pole anomalies through the natural pupil involves the area 
of the retina that could be seen at any one time with the various 
ophthalmoscopes. The approximately 40 degree field of view 
provided by the 8 10 1 2 made it easier to detect gradations in color 
and texture corresponding to pigment anomalies such as hypertrophy 
and window defects; red hemorrhages and other vascular anomalies 
also seemed to stand out better (i.e., have more contrast against the 
background of the fundus) with the larger field of view afforded by 
the 810. 
The larger field of view was also advantageous for examining 
subjects' fundi because it increased the probability that a lesion 
would be within the examiner's field of view at some time during 
the examination. Simple geometric calculations (which neglect 
overlapping circular fields of view, curvature of the retina, etc.) 
illustrate this point. According to Borish 12 , the field of view for a 
BIO with a 200 lens is approximately 40 degrees, the field of view 
for an MIO is approximately 22 degrees, and the direct 
ophthalmoscope has a field of view of approximately 10 degrees. 
This means that, under ideal conditions, to cover the area of the 
posterior pole (about 120 degrees between vortex vein insertions), 
approximately 9 fixations with the 810 would be required, the MIO 
would have to be positioned approximately 30 times, and the direct 
would have to be moved to approximately 144 different locations on 
the retina! Given the duration of a typical posterior pole 
examination, it is not surprising that more anomalies were found 
with the BIO than with the direct. The greater magnification 
afforded by the direct ophthalmoscope may be useful in studying 
anomalies which have already been found, but can be a handicap when 
simply searching for anomalies in the posterior pole. In this study, 
the direct ophthalmoscope was just not as good a tool for finding 
certain types of anomalies as was the BIO (or, to a lesser extent, the 
MIO). 
In spite of the limitations of the direct ~ ophthalmoscope, 
examining the posterior pole with this instrument seems to be the 
current standard of practice for optometry. Is this standard good 
enough? Should it be changed? Natural pupil fundus evaluations are 
relatively quick (about 1.0 min of observation time per eye in this 
study), involve minimal inconvenience for doctor and patient, and 
found over half of the posterior pole anomalies in this study. 
Dilated examinations take longer (about 5 min of observation time 
per eye in this study, plus the time associated with patient 
explanations, drug instillation, waiting for mydriasis, etc.), and 
involve more risk (albeit minimal) for the doctor and patient. 
To decide whether to change the current standard of 
optometric care, public health experts might subject the problem to 
a cost-effectiveness analysis in which the costs (expenses, risks, 
etc.) associated with each examination technique are compared to 
the number and importance of the anomalies that would be 
detected .1 3 In other fields, such cost-effectiveness analyses have 
led to very interesting and controversial conclusions. For example, 
it had been recommended that pap smears for cervical cancer be 
done every three years rather than every year as was the previous 
standard of medical practice. 14 From an efficiency and cost 
containment standpoint, the three year examination cycle seems 
best but from an individual patient's perspective (especially one 
whose cancer has gone undetected for the extra two years), the 
cost-effectiveness analysis may not be very meaningful. Similarly, 
it seems logical that dilation on a three to five year cycle might be 
cost-effective but there could be an increase in the risk of missing 
anomalies which would have been detected if the patient had been 
dilated more frequently. 
Another analogy might help to put the dilation versus natural 
pupil examination question into perspective. Typically, physicians 
use a stethoscope for checking the health of the heart even though 
most know that more complete information could be obtained with 
the electrocardiogram (ECG). The ECG is, however, often reseNed 
for those patients who have signs or symptoms of cardiac 
difficulties. Perhaps the use of signs and symptoms suggesting an 
ocular disease would lead to a more cost-effective determination 
about when to dilate. 
To evaluate this possibility, histories of subjects with and 
without type A anomalies were compared. The comparison was 
based on questions regarding 14 conditions (such as flashes and 
floaters, ocular/head trauma, diabetes, sudden field or acuity loss, 
etc.) which were listed by Alexander and Scholles6 as definite 
indications for dilation. Of the 44 subjects with type A anomalies, 
six (14%) did not respond positively to any of the questions 
regarding these conditions and so would not have been dilated if 
history had been the only criterion used. Conversely, 77% of the 458 
subjects without a type A anomaly responded positively to one or 
more of the history questions and thus would have been false 
positives. Clearly, the history questions used in this study did not 
produce a cost-effective method for determining who needed to be 
dilated. 
Perhaps in the future a refined set of history questions, in 
combination with considerations regarding the patient's age, etc., 
could be used to make a more cost-effective decision regarding 
dilation, but at this time deciding who and when to dilate remains 
open to the individual optometrist's judgement. It seems clear, 
however, that ophthalmoscopy through the natural pupil is not a very 
effective technique for detecting posterior pole anomalies (and 
certainly not for finding peripheral anomalies). The optometrist 
who wishes to provide the best possible care must, therefore, 
seriously consider dilating all patients in order to maximize the 
probability of detecting posterior pole and peripheral anomalies. 
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APPENDIX 
Detection counts for individual anomalies[ For posterior pole 
anomalies, counts for natural pupil examinations are shown first and 
are separated from dilated examination counts by a slash. See text 
for details regarding areas observed, etc. 
POSTERIOR POLE ANOMALIES 
Age Groups 
20- 30- 40- 50- 60 
£a ~ ft_ ~ ~ 
Disc Anomalies 
Tilted Disc 2/2 3/2 1 I 1 1 I 1 
Coloboma 1 I 1 
Myopic/Scleral Crescent 1/2 2/3 4/4 1 I 1 
Notched Rim 2/2 
Atrophy/Pallor 0/2 
Physiological Elevation 0 I 1 0 I 1 
Congested Elevation 0/1 
Drusen 1 I 2 1 I 1 0 I 1 
Pigment Crescent 4/4 1 I 1 2/2 
Peripapillary Atrophy 1 I 1 1 I 1 0/1 2/2 5/8 
Gl ia/Berg meister's 6/6 1 I 1 2/2 1 I 1 
Medulated Nerves 1 I 1 
Macular Anomalies 
Pre-retinal Fibrosis 1 I 1 1 I 1 3/7 
Pigment Mottling 2/2 011 1 I 1 0/5 2/1 3 
Edema 0/1 
Resorbed Edema 0/1 0/1 
Drusen 0 I 1 1/2 1/5 2/6 3/8 
Histoplasmosis Scar 1 I 1 1 I 1 
Traumatic Scar 1 I 1 1 I 1 
Window Defect 1/2 
Vascular Anomalies 
Dot/Blot Hemorrhages 0/1 1/2 212 
Exudates 1 I 1 2/2 
Hypertensive Changes 3/4 811 2 
Vessel Malformations 0 I 1 1 I 1 1 I 1 
Pigment Anomalies 
Clumping 1/2 
Hypertrophy 112 7/8 213 314 1 I 1 
Window Defect 1/3 114 0 I 1 318 
Bone Spicules 0 I 1 
Non-specific 212 114 
Chorio-Retinal Scars 
Histoplasmosis OJ 1 1 I 1 1 I 1 
Toxoplasmosis 1 I 1 
Post-surgical 212 
Non-specific 212 1 I 1 1 /1 
Chorio-Retinal Atrophy 
Peripapillary 1/1 1 I 1 011 212 518 
Non-specific 112 1 I 1 
Nevi 
Choroidal 015 018 117 0/8 
Non-Disc Myelin 
Non-disc 1 I 1 0/1 0/1 
Retinal Degeneration 
Reticular Pigment 0/1 1 /1 
Vitreo-Retinal Traction 
Associated with Scar 
Non-specific 
Vitreous Anomalies 
Prominent Floater 
Posterior Detachment 
Asteroid Hyalosis 
Tumors 
Osteoma 
1 /1 
1 /1 
0/2 
0/1 
0/1 
1 /1 
3/6 5/7 3/10 
0/1 0/5 11/13 
1/1 3/3 
PERIPHERIAL ANOMALIES 
Vascular 
Blot/Dot Hemorrhages 
Varix of Vortex Vein 
Pigment Anomalies 
Clumping 
Hypertrophy 
Window Defect 
Bone Spicules 
Non-specific 
Chorio-Retinal Scars 
Post-surgical 
Non-specific 
20-
2.9. 
1 
8 
6 
1 
1 
Age Groups 
30- 40- 50-
~ ~ 5..a 
1 2 
4 1 
7 7 6 
8 7 4 
2 2 4 
1 1 
2 
60 
~ 
2 
7 
4 
1 
1 
1 
2 
Chorio-Retinal Atrophy 
Paving stone 5 1 3 6 14 1 2 
Non-specific 2 3 5 5 5 
Nevi 
Choroidal 2 1 4 2 1 
Myelin 
Non-disc 1 1 
Retinal Degeneration 
Lattice 3 3 2 1 2 
Snail Track 2 2 2 1 
Reticular Pigment 1 0 3 4 22 
Retinoschisis 1 2 1 1 
Retinal Holes/Tears 
Atrophic Hole 2 3 3 3 7 
Within Lattice or Snail Track 1 
Operculated 1 1 
Horse Shoe 2 
Vitreo-Retinal Traction 
White w/o Pressure 10 4 1 
With Pigment Clumping 1 4 1 1 1 
With Lattice or Snail Track 1 
With Retinoschisis 1 
With Scarring 1 
Non-specific 2 1 
Viterous Anomalies 
Prominent Floater 2 2 1 1 
Tumors 
Malignant Melanoma 1 
TABLE 1 - NORMATIVE DATA 
Age Mean Percent Decimal Lens lOP Angle Pupil Media 
Cateoory ~ Females ~ ~ (mm Hg) .Grade. Ll:rlml ~ 
20-29 25.4 (2.5) 55 0.9 (0.2) -3.2 (2.6) 15.7 (2.3) 3.9 (0.3) 5.1 (0.9) 0.0 (0.2) 
30-39 34.2 (2.7) 54 0.9 (0.5) -2.1 (2.6) 15.7 (2.6) 3.9 (0.4) 4.3 (0.8) 0.0 (0.1) 
40-49 46.1 (2.8) 62 0.9 (0.2) -1.6 (2.5) 16.3 (2.2) 3.7 (0.6) 4.1 (0.8) 0.0 (0.1) 
50-59 53.9 (2.8) 56 0.8 (0.2) -1.0 (2.8) 16.7 (2.6) 3.4 (0.7) 3.7 (0.7) 0.1 (0.3) 
60 Plus 68.4 (6.4) 67 0.7 (0.4) +0.6 (2.1) 17.1 (3.1) 3.2 (0.7) 3.5 (0.7) 0.6 (2.3) 
MEAN 45.2 (15.5) 59 0.8 (0.3) -1.1 (2.8) 16.3 (2.7) 3.7 (0.6) 4.1 (1.0) 0.2 (1.1) 
CATEGORY 
DISC 
Type A 
TypeO 
MACULAR 
Type A 
TypeO 
VASCULAR 
Type A 
Type 0 
PIGMENT 
Type A 
Type 0 
CHORIO-RETINAL 
SCARS 
Type A 
Type 0 
TABLE 2- ANOMALIES DETECTED 
ANOMALIES 
Notched rim tissue; elevation (congestion); optic atrophy/ 
pallor 
Tilted disc; coloboma; myopic/scleral crescent; elevation 
(physiological); drusen; pigment crescent; peripapillary 
atrophy; glia/Bergmeister's; medulated nerves 
Macular edema 
Pre-retinal fibrosis; pigment mottling; resorbed edema; 
drusen; histoplasmosis scar; traumatic scar; window defect 
Blot/dot hemorrhages; exudates; hypertensive changes 
Arterio-venous malformations; varix of the vortex vein 
Bone spicules 
Pigment clumping; hypertrophy; window defect; non-
specific 
None 
Histoplasmosis; toxoplasmosis; post-surgical; non-specific 
CHORIO-RETINAL 
ATROPHY 
Type A 
TypeO 
NEVI 
Type A 
Type 0 
NON-DISC 
MYELIN 
Type A 
TypeO 
RETINAL 
DEGENERATION 
Type A 
TypeO 
RETINAL HOLES/ 
TEARS 
Type A 
TypeO 
VITREO-RETINAL 
TRACTION 
Type A 
Type 0 
None 
Pavingstone degeneration; peripapillary atrophy; non-
specific 
None 
Choroidal 
None 
Myelin located away from disc 
Reti noschisis 
Lattice; snail track; reticular pigment 
Holes within lattice/snail track; operculated holes; horse 
shoe tears 
Atrophic holes 
Associated with lattice/snail track degeneration; associated 
with retinoschisis 
White without pressure; associated with pigment clumping; 
associated with scars; non-specific 
VITREOUS 
ANOMALIES 
Type A 
TypeO 
TUMORS 
Type A 
TypeO 
None 
Prominent floater; posterior attachment; asteroid hyalosis 
Malignant melanoma; osteoma 
None 
TABLE 3- SUBJECTS WITH ANOMALIES 
~GE Q8IEGQBY 
ANOMALY 
I:Yff_ 2.Q:2.2 ~ ~ ~ ~ ~ 
A (ONLY) 2 4 7 15 
A and 0 (BOTH) 2 2 5 17 'D 
0 (ONLY) 44 52 53 56 66 271 
TOTAL 46 56 56 65 90 313 
TABLE 4: POSTERIOR POLE ANOMALIES DETECTED 
CATEGORY 20-29 30-39 40-49 50-59 60 Plus TOTAL 
A 0 T A 0 T A 0 T A 0 T A 0 T A 0 T 
DISC 
ANOMALIES 
NON-DILATED 0 1 1 11 0 1 1 1 1 0 8 8 0 6 6 2 8 10 2 44 4 6 
DILATED 0 13 13 0 1 4 14 0 9 9 0 8 8 4 1 1 16 5 55 60 
%MISSED - 15 1 5 - 21 21 - 11 11 
-
25 25 60 27 38 6 0 20 23 
MACULAR 
ANOMALIES 
NON-DILATED 0 3 3 0 2 2 0 3 3 0 3 3 0 11 11 0 2 2 22 
DILATED 0 4 4 0 5 5 0 7 7 0 13 13 1 32 33 1 6 1 6 2 
%MISSED 
- 25 25 - 60 60 . 57 57 . 77 77 100 66 67 100 64 65 
VASCULAR 
ANOMALIES 
NON-DILATED 0 0 0 0 0 0 0 1 1 5 0 5 12 1 13 1 7 2 1 9 
DILATED 0 1 1 0 0 0 1 1 2 7 0 7 1 6 1 1 7 24 3 27 
%MISSED 
-
100 100 - . 
-
100 0 50 29 - 29 25 0 24 2 9 33 30 
PIGMENT 
ANOMALIES 
NON-DILATED 0 1 1 0 8 8 0 3 3 0 6 6 0 5 5 0 2 3 23 
DILATED 0 2 2 0 1 1 11 0 7 7 0 9 9 1 13 14 1 42 43 
%MISSED - 50 50 - 27 27 - 57 57 - 33 33 100 62 64 100 45 47 
CHORIO-RETINAL 
SCARS 
NON-DILATED 0 2 2 0 1 1 0 1 1 0 1 1 0 4 4 0 9 9 
DILATED 0 2 2 0 2 2 0 1 1 0 1 1 0 4 4 0 1 0 1 0 
%MISSED - 0 0 
- 50 50 - 0 0 - 0 0 - 0 0 . 1 0 1 0 
CHORIO-RETINAL 
ATROPHY 
NON-DILATED 0 1 1 0 2 2 0 0 0 0 3 3 0 5 5 0 1 1 1 1 
DILATED 0 1 1 0 3 3 0 1 1 0 3 3 0 8 a 0 1 6 1 6 
%MISSED 0 0 . 33 33 . 100 100 - 0 0 
-
38 38 
-
3 1 3 1 
NEVI 
NON-DILATED 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 1 1 
DILATED 0 0 0 0 5 5 0 8 8 0 7 7 0 8 8 0 28 28 
%MISSED 
-
- -
-
100 100 . 100 100 A 86 86 . 100 100 . 96 96 
NON-DISC 
MYELIN 
NON-DILATED 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 1 1 
DILATED 0 0 0 0 0 0 0 1 1 0 1 1 0 1 1 0 3 3 
%MISSED .• . 
-
. 
-
. 
- 0 0 . 100 100 & 100 100 . 66 66 
TABLE 4: POSTERIOR POLE ANOMALIES DETECTED 
CATEGORY 20-29 30-39 40-49 50-59 60 Plus TOTAL 
A 0 T A 0 T A 0 T A 0 T A 0 T A 0 T 
RETINAL 
DEGENERATION 
NON-DILATED 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 1 
DILATED 0 0 0 0 0 0 0 0 0 0 1 1 0 1 1 0 2 2 
%MISSED -· . -
-
. 
- -
. 
-
. 100 100 ~ 0 0 . 50 50 
RETINAL TEARS/ 
HOLES 
NON-DILATED 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
DILATED 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
%MISSED - . - . . -
-
. 
-
. . . 
-
. . . . 
VITREO-RETINAL 
TRACTION 
NON-DILATED 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 1 
DILATED 0 0 0 0 0 0 0 0 0 0 2 2 0 1 1 0 3 3 
%MISSED 
-
. 
-
. 
- -
. . 
-
. 100 100 . 0 0 . 66 66 
VITREOUS 
ANOMALIES 
NON-DILATED 0 1 1 0 0 0 0 4 4 0 5 5 0 17 17 0 27 27 
DILATED 0 1 1 0 2 2 0 8 8 0 1 2 1 2 0 44 44 0 67 67 
%MISSED - 0 0 - 100 100 - 50 50 - 58 58 - 61 61 . 60 60 
TUMORS 
NON-DILATED 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 
DILATED 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 
%MISSED 0 - 0 - - - - - - - - - - - 0 . 0 
TOTALS 
NON-DILATED 1 1 9 20 0 2 4 24 0 2 1 2 1 5 25 30 1 4 53 67 20 142 162 
DILATED 1 24 25 0 4 2 4 2 1 43 4 4 7 57 64 23 124 147 3 2 290 322 
%MISSED 0 2 1 2 0 . 43 43 100 5 1 52 29 56 53 39 57 54 38 5 1 50 
TABLE 5: PERIPHERAL ANOMALIES DETECTED 
CATEGORY 20-29 30-39 40-49 50-59 60 Plus TOTAL 
A 0 T A 0 T A 0 T A 0 T A 0 T A 0 T 
VASCULAR 0 1 1 1 4 5 0 0 0 2 1 3 3 0 3 6 6 1 8 
ANOMALIES 
PIGMENT 0 15 15 0 18 18 0 17 17 0 14 14 1 13 14 1 77 78 
ANOMALIES 
CHORIO-RETINAL 0 1 1 0 2 2 0 0 0 0 0 0 0 2 2 0 5 5 
SCARS 
CHORIO-RETINAL 0 7 7 0 1 5 15 0 11 11 0 19 19 0 17 17 0 69 6 9 
ATROPHY 
NEVI 0 2 2 0 1 1 0 4 4 0 2 2 0 1 1 0 1 0 1 0 
NON-DISC 0 0 0 0 1 1 0 0 0 0 1 1 0 0 0 0 2 2 
MYELIN 
RETINAL 1 5 6 2 5 7 1 7 8 0 5 5 1 25 26 5 47 52 
DE GENERA TlON 
RETINAL TEARS/ 0 2 2 1 3 4 0 3 3 1 3 4 3 7 10 5 1 8 2 3 
HOLES 
VITREO-RETI NAL 1 13 1 4 0 9 9 1 1 2 0 1 1 0 3 3 2 27 29 
TRACTION 
VITREOUS 0 2 2 0 2 2 0 1 1 0 0 0 0 1 1 0 6 6 
ANOMALIES 
TUMORS 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 1 0 1 
TOTALS 2 4 8 50 4 60 64 2 44 4 6 3 46 49 9 69 78 20 267 287 
